Preclinical News and Research

RSS

New methods for heart monitoring could transform cardiovascular care

Chocolate valentines and candies with sweet sayings shouldn't be the only hearts you think about this February.

1 Feb 2024

Researchers discover new class of compound that targets cancer stem cells

Many cancer therapies, in addition to producing numerous side effects, fail to achieve complete tumour remission, partly due to the presence of cancer stem cells, which are difficult to eradicate.

31 Jan 2024

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

A researcher at the University of Houston College of Pharmacy Drug Discovery Institute is working to revolutionize treatment regimens for triple-negative breast cancer (TNBC) by proving that nebivolol, an FDA-approved drug for high blood pressure, is effective in treating it.

31 Jan 2024

AI-based applications for personalized cancer medicine and related regulatory challenges: An overview

Personalized therapies could improve the treatment of many diseases in the future. Cancer medicine in particular has made significant progress in recent years.

31 Jan 2024

CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC market

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Joseph Parisi as US Director of Sales. In his new role, Joe will lead the expansion of the Company’s sales and support activities for the US market to address the growing demand for new alternative methodologies (NAMs) in preclinical drug discovery.

31 Jan 2024

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, today announced that it has closed a £26 million ($33.1 million USD) Series B follow-on financing round, led by Panakes Partners.

From Enterprise Therapeutics Ltd 31 Jan 2024

Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.

30 Jan 2024

How do mass spectrometry and omics impact neurosciences?

In this new episode of omg OMx, Kate Stumpo speaks to Sapient's Tanya Nguyen about the role of omics and mass spectrometry in neurosciences.

From Bruker Life Sciences Mass Spectrometry 30 Jan 2024

Fermented foods linked to mental health benefits through gut-brain connection

Researchers explore the mental health benefits of fermented foods on the microbiota-gut-brain axis, highlighting the need for further studies to understand their therapeutic potential.

29 Jan 2024

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

NewsMedical speaks with Chao Ma, Ph.D. a Research Assistant Professor at New York University Tandon School of Engineering, ahead of his presentation at SLAS 2024.

From Society for Laboratory Automation and Screening (SLAS) 29 Jan 2024

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

A large cohort study in "JAMA Pediatrics" found no significant differences in neurodevelopmental rates between infants exposed to COVID-19 vaccines in-utero and those who were not, affirming the safety of maternal COVID-19 vaccination.

24 Jan 2024

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Researchers analyzed the toxicity concerns and advancements in mRNA therapeutics, focusing on their cellular toxicity, reactogenicity, and distribution, and discussed the challenges and benefits of mRNA research.

24 Jan 2024

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

From Calluna Pharma 24 Jan 2024

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

24 Jan 2024

3D-printed liver model paves way for new MASH treatments

Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly 24% of adults having nonalcoholic fatty liver disease (NAFLD).

23 Jan 2024

Preclinical News and Research

New methods for heart monitoring could transform cardiovascular care

Researchers discover new class of compound that targets cancer stem cells

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

AI-based applications for personalized cancer medicine and related regulatory challenges: An overview

CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC market

Enterprise Therapeutics closes £26 million ($33.1 million) Series B follow-on financing

Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy

How do mass spectrometry and omics impact neurosciences?

Fermented foods linked to mental health benefits through gut-brain connection

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

3D-printed liver model paves way for new MASH treatments

Scientists identify a new approach to treating sarcoidosis

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

Unveiling hidden TB risk with cutting-edge techniques

COST Action bridges the gap in cancer immunotherapy research

Immune checkpoint inhibitor target found to promote skin cancer growth

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News